Expression of Tim-3/Galectin-9 pathway and CD8+T cells and related factors in patients with cystic echinococcosis

被引:0
|
作者
Zhao, Hui [2 ,3 ]
Ma, Yuyu [3 ]
Tian, Fengming [3 ]
Li, Bin [3 ]
Xiao, Ning [1 ]
Mo, Xiaojin [1 ]
Aibibula, Madinaimu [3 ]
Min, Hongyue [3 ]
Cai, Xuanlin [3 ]
Zhang, Ting [1 ]
Ma, Xiumin [3 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Chinese Ctr Trop Dis Res, Natl Inst Parasit Dis, NHC Key Lab Parasite & Vector Biol, Shanghai, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 1, Med Testing Ctr, Urumqi, Xinjiang, Peoples R China
[3] Xinjiang Med Univ, Tumor Hosp, Clin Lab Ctr, State Key Lab Pathogenesis Prevent & Treatment Hig, Urumqi 830011, Xinjiang, Peoples R China
关键词
Cystic echinococcosis; Tim-3/Galectin-9; pathway; CD8+T cells; CTL; CD8+CD28-T cells; IMMUNOGLOBULIN-G SUBCLASS; T-CELLS; RESPONSES; EXHAUSTION; TIM-3;
D O I
10.1016/j.exppara.2023.108623
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Objective: One of the primary reasons for the successful patriotization of Echinococcus multilocularis in patients is its ability to induce host immune tolerance. This study examined the expression of the immunosuppressive Tim-3/Galectin-9 pathway, CD8+T cells, and related factors in AE patients. The aim was to analyze the relationship between the Tim-3/Galectin-9 pathway and CD8+T cells in this disease and further understand the mechanism of immune tolerance induced by cystic echinococcosis. Methods: Using flow cytometry, we evaluated the expression of CTL, CD8(+)CD28-T cells, CD8(+)CD28 + IFN-gamma + T cells, CD8(+)CD28+perforin + T cells, CD8(+)CD28+granzyme B + T cells, CD8(+)CD28-IL-10 + T cells, CD8(+)CD28-TGF-beta+T cells, and Tim-3 expression on CD8+T cells in the peripheral blood of control (n = 30) and AE patients (n = 33). qRT-PCR was used to measure CD107a and Tim-3/Galectin-9 mRNA levels in PBMCs from the control and AE groups. Immunohistochemistry was employed to detect IL-10, TGF-beta, and Tim-3/Galectin-9 expressions in the infected livers of AE patients. Results: AE patients exhibited a significant decrease in peripheral blood CTL ratio (P < 0.001) and an increase in CD8(+)CD28+IFN-gamma+T cell ratio (P < 0.001). No significant changes were observed in the ratios of CD8(+)CD28+perforin + T cells (P = 0.720) and CD8(+)CD28+granzyme B + T cells (P = 0.051). The proportions of CD8(+)CD28-T cells (P < 0.001), CD8(+)CD28-IL-10 + T cells (P < 0.001), and CD8(+)CD28-TGF-beta+T cells (P < 0.001) were notably higher than in the control group. The expression of Tim-3 on CTL and CD8(+)CD28-T cells in AE patients was significantly upregulated (P < 0.001, P < 0.001). AE patients displayed a substantial decrease in peripheral blood PBMC CD107a mRNA levels (P < 0.001) and significant elevations in Tim-3/Galectin-9 mRNA levels (P < 0.001, P < 0.001). A negative correlation was observed between CD107a mRNA levels and both Tim-3 (r<^>2 = 0.411, P < 0.001) and Galectin-9 (r(2) = 0.180, P = 0.019) mRNA levels. Expressions of IL-10 (P < 0.001), TGF-beta (P < 0.001), and Tim-3/Galectin-9 (P < 0.001, P < 0.001) in AE patient-infected livers were significantly higher than in uninfected regions. IL-10 and TGF-beta expressions showed a positive correlation with Tim-3/Galectin-9. Conclusion" This study suggests that the high expression of Tim-3 on CD8+T cell surfaces in AE patients might promote an increase in CD8(+)CD28-T cells and related factors, while suppressing CTL and related factor expressions. This potentially induces the onset of immune tolerance, which is unfavorable for the clearance of Echinococcus multilocularis in patients, leading to the exacerbation of persistent infections.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] TIM-3/Galectin-9 and CD160 expression in salivary adenoid cystic carcinoma
    Li, Mao
    Wan, Zi-xin
    Tang, Yue-yang
    Liang, Xin-hua
    Tang, Ya-ling
    ORAL DISEASES, 2024, 30 (04) : 2262 - 2274
  • [2] Tim-3:Galectin-9 pathway expands myeloid suppressor cells
    Dardalhon, Valerie
    Anderson, Ana
    Korman, Jozsef
    Chandwaskar, Rucha
    Lee, David
    Cornejo, Melanie
    Nishi, Nozomu
    Yamauchi, Akira
    Sobel, Raymond
    Hiroshima, Mitsuomi
    Kuchroo, Vijay
    CLINICAL IMMUNOLOGY, 2008, 127 : S12 - S12
  • [3] Peripheral Blood TIM-3 Positive NK and CD8+T Cells throughout Pregnancy: TIM-3/Galectin-9 Interaction and Its Possible Role during Pregnancy
    Meggyes, Matyas
    Miko, Eva
    Polgar, Beata
    Bogar, Barbara
    Farkas, Balint
    Illes, Zsolt
    Szereday, Laszlo
    PLOS ONE, 2014, 9 (03):
  • [4] Inhibitory pathway TIM-3/Galectin-9 in patients with Multiple Sclerosis
    Saresella, Marina
    Marventano, Ivana
    Piancone, Federica
    Tortorella, Paola
    Caputo, Domenico
    Rovaris, Marco
    Clerici, Mario
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 77 - 77
  • [5] Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis
    Shaoyu Li
    Yuejie Zhu
    Song Wang
    Yujiao Li
    Nannan Pang
    Mengting An
    Fengbo Zhang
    Jianbing Ding
    Molecular Biology Reports, 2022, 49 : 7497 - 7506
  • [6] Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis
    Li, Shaoyu
    Zhu, Yuejie
    Wang, Song
    Li, Yujiao
    Pang, Nannan
    An, Mengting
    Zhang, Fengbo
    Ding, Jianbing
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (08) : 7497 - 7506
  • [7] Regulation of virus-specific acute and memory CD8+T cell response by Galectin-9/TIM-3 interaction
    Sehrawat, Sharvan
    Hirashima, Mitsuomi
    Rouse, Barry
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [8] The Galectin-9/TIM-3 pathway and human glioma pathogenesis
    Zheng, Chengjie
    Kuchroo, Juhi
    Anderson, David E.
    CLINICAL IMMUNOLOGY, 2007, 123 : S142 - S142
  • [9] Role of TIM-3/Galectin-9 pathway in lung cancer
    Ohue, Yoshihiro
    Kurose, Koji
    Nishio, Yumi
    Isobe, Midori
    Oka, Mikio
    Nakayama, Eiichi
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [10] High Expression of Tim-3 in Alveolar Echinococcosis Mediates Depletion of CD8+T Cell Function
    Zhao, Hui
    Li, Bin
    Pang, Nannan
    Li, Zhiwei
    Aibibula, Maidinaimu
    Tian, Fengming
    Cai, Xuanlin
    Li, Yujiao
    Ding, Jianbing
    Ma, Xiumin
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (06): : 827 - 836